Maintaining balance against force perturbations: impaired mechanisms unresponsive to levodopa in Parkinson's disease

Irene Di Giulio, Rebecca J St George, Eirini Kalliolia, Amy L Peters, Patricia Limousin, Brian L Day, Irene Di Giulio, Rebecca J St George, Eirini Kalliolia, Amy L Peters, Patricia Limousin, Brian L Day

Abstract

There is evidence that postural instability associated with Parkinson's disease (PD) is not adequately improved by levodopa, implying involvement of nondopaminergic pathways. However, the mechanisms contributing to postural instability have yet to be fully identified and tested for their levodopa responsiveness. In this report we investigate balance processes that resist external forces to the body when standing. These include in-place responses and the transition to protective stepping. Forward and backward shoulder pulls were delivered using two force-feedback-controlled motors and were randomized for direction, magnitude, and onset. Sixteen patients with PD were tested OFF and ON levodopa, and 16 healthy controls were tested twice. Response behavior was quantified from 3-dimensional ground reaction forces and kinematic measurements of body segments and total body center-of-mass (CoM) motion. In-place responses resisting the pull were significantly smaller in PD as reflected in reduced horizontal anteroposterior ground reaction force and increased CoM displacement. Ankle, knee, and hip moments contributing to this resistance were smaller in PD, with the knee extensor moment to backward pulls being the most affected. The threshold force needed to evoke a step was also smaller for PD in the forward direction. Protective steps evoked by suprathreshold pulls showed deficits in PD in the backward direction, with steps being shorter and more steps being required to arrest the body. Levodopa administration had no significant effect on either in-place or protective stepping deficits. We conclude that processes employed to maintain balance in the face of external forces show impairment in PD consistent with disruption to nondopaminergic systems.

Keywords: Parkinson's disease; balance; dopaminergic pathways; levodopa; postural instability; pull test.

Copyright © 2016 the American Physiological Society.

Figures

Fig. 1.
Fig. 1.
Apparatus. Participants stood on two force platforms and wore a safety harness. Two motors delivered 1-s-long pulls of different force and direction (backward and forward) via kite strings attached at shoulder level. Participants were asked to resist the pull unless one or more steps became necessary to maintain balance.
Fig. 2.
Fig. 2.
Whole body in-place responses. A: group mean (n = 16) responses for PD (black lines) and controls (gray lines) to 10-N pulls in the backward direction for session 1 (PD OFF; dashed lines) and session 2 (PD ON; solid lines). Top, perturbation force; middle, center of mass (CoM) displacement normalized by body mass; bottom, anteroposterior (AP) ground reaction force. B: group mean (±SE) AP reaction force measured between 0 and 500 ms after pull onset for PD (squares, black lines) and controls (circles, gray lines). Data from force levels of 10 N (open symbols) and 20 N (filled symbols) are shown separately for each session (S1, OFF; S2, ON) and each direction (backward, forward). C: same conventions as B for the mean normalized CoM displacement measured at the end of perturbation.
Fig. 3.
Fig. 3.
In-place joint moments. Combined left and right joint moments in the sagittal plane were measured between 0 and 500 ms after pull onset. Moments were normalized by pull force and averaged across 10- and 20-N pulls and across sessions. Group means (±SE) are shown separately for backward (left) and forward (right) perturbations in PD (squares, black lines) and controls (circles, gray lines). Direction of moments is shown as dorsiflexion (DF) or plantarflexion (PF) for ankle and extension (E) or flexion (F) for knee and hip.
Fig. 4.
Fig. 4.
Stepping threshold. A: example of sigmoid curve using all trials collected in one session from a representative participant for calculation of stepping threshold (before normalization). B: group mean (±SE) stepping threshold normalized by body mass in each session (S1, OFF; S2, ON) for PD (black squares) and controls (gray circles) shown separately for backward (solid lines) and forward (dashed lines) pulls.
Fig. 5.
Fig. 5.
Stepping responses. A: representative PD and control participants for 29-N backward pull. Top, perturbation force (solid black lines); bottom, AP position of CoM (dashed black), and heels (R, right, solid dark gray lines; L, left, solid light gray lines). Although the pulls were identical and the body displacement (CoM trajectory) and foot-lift time were similar, the PD patient took multiple short steps, whereas the control participant took a single longer step. B: group mean (±SE) length of first step for PD patients (squares, black lines) and controls (circles, gray lines) for each session (S1, OFF; S2, ON) in the backward (left) and forward (right) directions. C: same conventions as B for group mean (±SE) number of steps taken per trial.

References

    1. Balash Y, Peretz C, Leibovich G, Herman T, Hausdorff JM, Giladi N. Falls in outpatients with Parkinson's disease. Frequency, impact and identifying factors. J Neurol 252: 1310–1315, 2005.
    1. Bejjani BP, Gervais D, Arnulf I, Papadopoulos S, Demeret S, Bonnet AM, Cornu P, Damier P, Agid Y. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 68: 595–600, 2000.
    1. Benarroch EE. Pedunculopontine nucleus. Functional organization and clinical implications. Neurology 80: 1148–1155, 2013.
    1. Bloem BR, Beckley DJ, van Dijk JG, Zwinderman AH, Remler MP, Roos RA. Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease. Mov Disord 11: 509–521, 1996.
    1. Bloem BR, Beckley DJ, van Hilten BJ, Roos RA. Clinimetrics of postural instability in Parkinson's disease. J Neurol 245: 669–673, 1998.
    1. Bohnen NI, Muller ML, Koeppe RA, Studenski SA, Kilbourn MA, Frey KA, Albin RL. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology 73: 1670–1676, 2009.
    1. Bonnet AM, Loria Y, Saint-Hilaire MH, Lhermitte F, Agid Y. Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology 37: 1539–1542, 1987.
    1. Burn DJ. The effects of deep brain stimulation and levodopa on postural sway in subjects with Parkinson's disease. J Neurol Neurosurg Psychiatry 73: 240, 2002.
    1. Carpenter MG, Allum JH, Honegger F, Adkin AL, Bloem BR. Postural abnormalities to multidirectional stance perturbations in Parkinson's disease. J Neurol Neurosurg Psychiatry 75: 1245–1254, 2004.
    1. de Kam D, Nonnekes J, Oude Nijhuis LB, Geurts ACH, Bloem BR, Weerdesteyn V. Dopaminergic medication does not improve stepping responses following backward and forward balance perturbations in patients with Parkinson's disease. J Neurol 261: 2330–2337, 2014.
    1. DeLong M. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13: 281–285, 1990.
    1. Dimitrova D, Nutt J, Horak FB. Abnormal force patterns for multidirectional postural responses in patients with Parkinson's disease. Exp Brain Res 156: 183–195, 2004.
    1. Filion M, Tremblay L, Bedard PJ. Abnormal influences of passive limb movement on the activity of the globus pallidus neurons in parkinsonian monkeys. Brain Res 444: 165–176, 1988.
    1. Foreman KB, Wisted C, Addison O, Marcus RL, LaStayo PC, Dibble LE. Improved dynamic postural task performance without improvements in postural responses: the blessing and the curse of dopamine replacement. Parkinsons Dis 2012: 692150, 2012.
    1. Frenklach A, Louie S, Miller Koop M, Bronte-Stewart H. Excessive postural sway and the risk of falls at different stages of Parkinson's disease. Mov Disord 24: 377–385, 2009.
    1. Guehl D, Dehail P, de Seze MP, Cuny E, Faux P, Tison F, Barat M, Bioulac B, Burbaud P. Evolution of postural stability after subthalamic nucleus stimulation in Parkinson's disease: a combined clinical and posturometric study. Exp Brain Res 170: 206–215, 2006.
    1. Hely MA, Morris JGL, Reid WGJ, Trafficante R. Sydney multicenter study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 20: 190–199, 2005.
    1. Hirsch E, Graybiel AM, Duyckaerts C, Jovoy-Agid F. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci USA 84: 5976–5980, 1987.
    1. Horak FB, Frank J, Nutt J. Effects of dopamine on postural control in Parkinsonian subjects: scaling, set and tone. J Neurophysiol 75: 2380–2396, 1996.
    1. Horak FB, Nutt JG, Nashner LM. Postural inflexibility in parkinsonian subjects. J Neurol Sci 111: 46–58, 1992.
    1. Jacobs JV, Horak FB. Abnormal proprioceptive-motor integration contributes to hypometric postural responses of subjects with Parkinson's disease. Neuroscience 141: 999–1009, 2006.
    1. Jöbges M, Heuschkel G, Pretzel C, Illhardt C, Renner C, Hummelsheim H. Repetitive training of compensatory steps: a therapeutic approach for postural instability in Parkinson's disease. J Neurol Neurosurg Psychiatry 75: 1682–1687, 2004.
    1. Kim SD, Allen NE, Canning CG, Fung VSC. Postural instability in patients with Parkinson's disease. CNS Drugs 27: 97–112, 2013.
    1. King LA, St George RJ, Carlson-Kuhta P, Nutt JG, Horak FB. Preparation for compensatory forward stepping in Parkinson's disease. Arch Phys Med Rehabil 91: 1332–1338, 2010.
    1. Koller WC, Glatt S, Vetere-Overfield B, Hassanein R. Falls and Parkinson's disease. Clin Neuropharmacol 12: 98–105, 1989.
    1. Konczak J, Corcos DM, Horak FB, Poizner H, Shapiro M, Tuite P, Volkmann J, Maschke M. Proprioception and motor control in Parkinson's disease. J Mot Behav 41: 543–552, 2009.
    1. Lee PY, Gadareh K, Naushahi MJ, Gresty M, Bronstein AM. Protective stepping response in parkinsonian patients and the effect of vibrotactile feedback. Mov Disord 28: 482–489, 2013.
    1. McVey MA, Amundsen S, Barnds A, Lyons K, Pahwa R, Mahnken JD, Luchies CW. The effect of moderate Parkinson's disease on compensatory backwards stepping. Gait Posture 38: 800–805, 2013.
    1. Muller MLTM, Albin RL, Kotagal V, Koeppe RA, Schott PJH, Frey KA, Bohnen NI. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease. Brain 136: 3282–3289, 2013.
    1. Oude Nijhuis LB, Allum JH, Nanhoe-Mahabier W, Bloem BR. Influence of Perturbation velocity on balance control in Parkinson's disease. PLoS One 9: e86650, 2014.
    1. Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain 123: 1767–1783, 2000.
    1. Pai YC, Rogers MW, Patton J, Cain TD, Hanke TA. Static versus dynamic predictions of protective stepping following waist-pull perturbations in young and older adults. J Biomech 31: 1111–1118, 1998.
    1. Pang MY, Mak MK. Influence of contraction type, speed, and joint angle on ankle muscle weakness in Parkinson's disease: implications for rehabilitation. Arch Phys Med Rehabil 93: 2352–2359, 2012.
    1. Pijnappels M, Bobbert MF, van Dieen JH. Changes in walking pattern caused by the possibility of a tripping reaction. Gait Posture 14: 11–18, 2001.
    1. Rinne JO, Ma SY, Lee MS, Collan Y, Roytta M. Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients. Parkinsonism Relat Disord 14: 553–557, 2008.
    1. Rocchi L, Chiari L, Horak FB. Effects of deep brain stimulation and levodopa on postural sway in Parkinson's disease. J Neurol Neurosurg Psychiatry 73: 267–274, 2002.
    1. Rogers MW, Hedman LD, Johnson ME, Martinez KM, Mille ML. Triggering of protective stepping for the control of human balance: age and contextual dependence. Cogn Brain Res 16: 192–198, 2003.
    1. Schieppati M, Nardone A. Free and supported stance in Parkinson's disease. Brain 114: 1227–1244, 1991.
    1. Schrag A, Choudhury M, Kaski D, Gallagher DA. Why do patients with Parkinson's disease fall? A cross-sectional analysis of possible causes of falls. NPJ Parkinsons Dis 1: 2015.
    1. Smulders K, Esselink RA, De Swart BJ, Geurts AC, Bloem BR, Weerdesteyn V. Postural inflexibility in PD: does it affect compensatory stepping? Gait Posture 39: 700–706, 2014.
    1. Steiger MJ, Thompson PD, Marsden CD. Disordered axial movement in Parkinson's disease. J Neurol Neurosurg Psychiatry 61: 645–648, 1996.
    1. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinsons' disease. Mov Disord 25: 2649–2685, 2010.
    1. Viitasalo MK, Kampman V, Sotaniemi KA, Leppavuori S, Myllyla VV, Korpelainen JT. Analysis of sway in Parkinson's disease using a new inclinometry-based method. Mov Disord 17: 663–669, 2002.
    1. Zweig RM, Janke WR, Hedreen JC, Mayeux R, Price DL. The pedunculopontine nucleus in Parkinson's disease. Ann Neurol 26: 41–46, 1989.

Source: PubMed

3
購読する